Zhong XP - Search Results

1

A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma.

Mei J, Li SH, Wang QX, Zhong XP, Lu LH, Kan A, Wei W, Guo RP. Mei J, et al. Among authors: zhong xp. Cancer Med. 2020 Jan;9(1):62-76. doi: 10.1002/cam4.2671. Epub 2019 Nov 8. Cancer Med. 2020. PMID: 31701652 Free PMC article.

2

Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis.

Zhang YF, Le Y, Wei W, Zou RH, Wang JH, OuYang HY, Xiao CZ, Zhong XP, Shi M, Guo RP. Zhang YF, et al. Among authors: zhong xp. Oncotarget. 2016 Jun 21;7(25):38845-38856. doi: 10.18632/oncotarget.8642. Oncotarget. 2016. PMID: 27072577 Free PMC article.

3

Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus.

Zhang YF, Wei W, Wang JH, Xu L, Jian PE, Xiao CZ, Zhong XP, Shi M, Guo RP. Zhang YF, et al. Among authors: zhong xp. Onco Targets Ther. 2016 Jul 12;9:4239-46. doi: 10.2147/OTT.S106659. eCollection 2016. Onco Targets Ther. 2016. PMID: 27471398 Free PMC article.

4

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.

Wang JH, Zhong XP, Zhang YF, Wu XL, Li SH, Jian PE, Ling YH, Shi M, Chen MS, Wei W, Guo RP. Wang JH, et al. Among authors: zhong xp. Cell Death Dis. 2017 Sep 7;8(9):e3043. doi: 10.1038/cddis.2017.428. Cell Death Dis. 2017. PMID: 28880268 Free PMC article.

5

ELTD1 Function in Hepatocellular Carcinoma is Carcinoma-Associated Fibroblast-Dependent.

Kan A, Le Y, Zhang YF, Duan FT, Zhong XP, Lu LH, Ling YH, Guo RP. Kan A, et al. Among authors: zhong xp. J Cancer. 2018 Jun 14;9(14):2415-2427. doi: 10.7150/jca.24406. eCollection 2018. J Cancer. 2018. PMID: 30026838 Free PMC article.

6

Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma.

Lu LH, Zhang YF, Mu-Yan C, Kan A, Zhong XP, Mei J, Ling YH, Li SH, Shi M, Wei W, Guo RP. Lu LH, et al. Among authors: zhong xp. Dig Liver Dis. 2019 Oct;51(10):1430-1437. doi: 10.1016/j.dld.2019.04.006. Epub 2019 May 1. Dig Liver Dis. 2019. PMID: 31054962 Free article.

7

NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma.

Zhong XP, Kan A, Ling YH, Lu LH, Mei J, Wei W, Li SH, Guo RP. Zhong XP, et al. Cell Death Dis. 2019 May 8;10(5):369. doi: 10.1038/s41419-019-1603-4. Cell Death Dis. 2019. PMID: 31068575 Free PMC article.

8

CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.

Zhong X, Kan A, Zhang W, Zhou J, Zhang H, Chen J, Tang S. Zhong X, et al. Aging (Albany NY). 2019 Aug 2;11(15):5483-5497. doi: 10.18632/aging.102132. Epub 2019 Aug 2. Aging (Albany NY). 2019. PMID: 31375643 Free PMC article.

9

Anatomical versus Non-anatomical Resection for Hepatocellular Carcinoma with Microscope Vascular Invasion: A Propensity Score Matching Analysis.

Zhong XP, Zhang YF, Mei J, Li SH, Kan A, Lu LH, Chen MS, Wei W, Guo RP. Zhong XP, et al. J Cancer. 2019 Jul 5;10(17):3950-3957. doi: 10.7150/jca.32592. eCollection 2019. J Cancer. 2019. PMID: 31417639 Free PMC article.

10

Risk factors of extra-hepatic progression after transarterial chemoembolization for hepatocellular carcinoma patients: a retrospective study in 654 cases.

Li S, Wang Q, Mei J, Wang J, Zhong XP, Ling Y, Guo Z, Lu LH, Wei W, Guo R. Li S, et al. Among authors: zhong xp. J Cancer. 2019 Aug 27;10(20):5007-5014. doi: 10.7150/jca.35355. eCollection 2019. J Cancer. 2019. PMID: 31598173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters